Literature DB >> 21791417

Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.

Yuko Suzuki1, Hideki Yasui, Tomasz Brzoska, Hideo Mogami, Tetsumei Urano.   

Abstract

In a previous study, we demonstrated unique secretory dynamics of tissue plasminogen activator (tPA) in which tPA was retained on the cell surface in a heavy chain-dependent manner after exocytosis from secretory granules in vascular endothelial cells. Here, we examined how retained tPA expresses its enzymatic activity. Retained tPA effectively increased the lysine binding site-dependent binding of plasminogen on the cell surface and pericellular area; this was abolished by inhibition of enzymatic activity of either tPA or plasmin, which suggests that de novo generation of carboxyl-terminal lysine as a consequence of degradation of surface/pericellular proteins by plasmin is essential. Retained tPA initiated zonal clot lysis of a fibrin network that had been formed on vascular endothelial cells, which was preceded by the binding of plasminogen to the lysis front. Our results provide evidence that secreted and retained tPA is essential for maintaining both high fibrinolytic activity and effective clot lysis on the vascular endothelial cell surface.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791417     DOI: 10.1182/blood-2011-05-353912

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Endothelial cell attachment and shear response on biomimetic polymer-coated vascular grafts.

Authors:  Lynn A Dudash; Faina Kligman; Samantha M Sarett; Kandice Kottke-Marchant; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

2.  Activated platelet-based inhibition of fibrinolysis via thrombin-activatable fibrinolysis inhibitor activation system.

Authors:  Yuko Suzuki; Hideto Sano; Liina Mochizuki; Naoki Honkura; Tetsumei Urano
Journal:  Blood Adv       Date:  2020-11-10

3.  Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.

Authors:  Yasuhiro Suzuki; Nobuo Nagai; Kasumi Yamakawa; Yoshinori Muranaka; Kazuya Hokamura; Kazuo Umemura
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-29       Impact factor: 6.200

4.  Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.

Authors:  Tomasz Brzoska; Aki Tanaka-Murakami; Yuko Suzuki; Hideto Sano; Naohiro Kanayama; Tetsumei Urano
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

5.  Endothelial fibrinolytic response onto an evolving matrix of fibrin.

Authors:  O Castillo; H Rojas; Z Domínguez; E Anglés-Cano; R Marchi
Journal:  BMC Hematol       Date:  2016-04-14

6.  Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.

Authors:  Yuko Suzuki; Hideto Sano; Martyna Tomczyk; Tomasz Brzoska; Tetsumei Urano
Journal:  FEBS Open Bio       Date:  2016-04-01       Impact factor: 2.693

7.  Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.

Authors:  Tetsumei Urano; Yuko Suzuki
Journal:  J Biomed Biotechnol       Date:  2012-10-14

Review 8.  Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.

Authors:  Sakir Ahmed; Olena Zimba; Armen Yuri Gasparyan
Journal:  Clin Rheumatol       Date:  2020-07-11       Impact factor: 2.980

Review 9.  Regulation of plasminogen activation on cell surfaces and fibrin.

Authors:  T Urano; F J Castellino; Y Suzuki
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

10.  Deficiency of tPA Exacerbates White Matter Damage, Neuroinflammation, Glymphatic Dysfunction and Cognitive Dysfunction in Aging Mice.

Authors:  Peng Yu; Poornima Venkat; Michael Chopp; Alex Zacharek; Yi Shen; Linlin Liang; Julie Landschoot-Ward; Zhongwu Liu; Rongcai Jiang; Jieli Chen
Journal:  Aging Dis       Date:  2019-08-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.